Tower Research Capital LLC (Trc) Arcturus Therapeutics Holdings Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.68 Billion
- Q3 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 3,850 shares of ARCT stock, worth $67,067. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,850
Previous 3,041
26.6%
Holding current value
$67,067
Previous $74,000
20.27%
% of portfolio
0.0%
Previous 0.0%
Shares
22 transactions
Others Institutions Holding ARCT
# of Institutions
175Shares Held
25.5MCall Options Held
195KPut Options Held
133K-
Federated Hermes, Inc. Pittsburgh, PA4.69MShares$81.8 Million0.25% of portfolio
-
Black Rock Inc. New York, NY2.65MShares$46.2 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.2.32MShares$40.3 Million0.62% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl2.1MShares$36.6 Million0.46% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.2.07MShares$36 Million0.02% of portfolio
About Arcturus Therapeutics Holdings Inc.
- Ticker ARCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,576,400
- Market Cap $463M
- Description
- Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...